Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind repeat-dose two-period crossover study of inhaled fluticasone furoate/vilanterol in asthma
2012-000754-55Phase 2
- Sponsor
- GSK
- Start
- Aug 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluticasone propionate + vilanterol in asthma (2 arms), sponsored by GSK. Primary endpoint: Safety and tolerability.
02
Drugs
fluticasone propionate + vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2012-000754-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000754-55.